KaloCyte, Inc.
KaloCyte, Inc. is a pre-clinical stage healthcare biotech startup focused on developing ErythroMer™, a dried, bio-inspired artificial red blood cell. This innovative solution aims to address the critical need for blood substitutes in emergency situations where stored red blood cells are unavailable, undesirable, or in short supply. Founded by a team of experts in physiology, bioengineering, and trauma care, KaloCyte is supported by significant federal grants and investor funding, positioning it to advance to first-in-human trials.
Industries
Nr. of Employees
small (1-50)
KaloCyte, Inc.
670 West Baltimore Street, HSRF III, 8th Floor, Baltimore, Maryland 21201
Patents
Compositions and methods for removing bio-synthetic nano-particles from bodily fluids
US-12161765-B2
View Details
Compositions and methods for removing bio-synthetic nano-particles from bodily fluids
US-12161765-B2
View DetailsProducts
Dried, reconstitutable oxygen carrier (bio-inspired artificial red blood cell)
A freeze-dried powder formulation containing purified hemoglobin encapsulated in a soft lipid nanoparticle shell with a pH-responsive regulator to facilitate oxygen uptake in the lungs and release in hypoxic tissues; designed for ambient storage and rapid reconstitution for emergency transfusion.
Dried, reconstitutable oxygen carrier (bio-inspired artificial red blood cell)
A freeze-dried powder formulation containing purified hemoglobin encapsulated in a soft lipid nanoparticle shell with a pH-responsive regulator to facilitate oxygen uptake in the lungs and release in hypoxic tissues; designed for ambient storage and rapid reconstitution for emergency transfusion.
Services
Academic and government collaboration on preclinical R&D programs, participation as subcontractor in multi-institution government-funded consortia, and management of grant-funded projects supporting preclinical development.
Academic and government collaboration on preclinical R&D programs, participation as subcontractor in multi-institution government-funded consortia, and management of grant-funded projects supporting preclinical development.
Expertise Areas
- Artificial oxygen carrier development
- Nanomedicine and lipid nanoparticle formulation
- Lyophilization and ambient-stable formulation
- Preclinical safety and efficacy testing
Key Technologies
- Lipid nanoparticle encapsulation
- Lyophilization / freeze-drying
- Hemoglobin purification and nano-encapsulation
- pH-responsive small-molecule modulation of protein function
News & Updates
Unlock strategies and best practices for raising capital at the annual Women Founders and Funders breakfast, presented by Fox Rothschild and the Private Investors Forum.
Connect with key players from the private equity, venture capital, and entrepreneurial communities in a vibrant mix of company presentations and networking.
The symposium will highlight advances in the science and development of blood substitutes, with KaloCyte as a Silver Sponsor.
A celebration of Maryland’s entrepreneurial resources, featuring discussions on capital pathways for women entrepreneurs.
A new candidate, ErythroMer, is still in preclinical testing but could be more durable and versatile than the real thing.
The research park’s location and resources make it invaluable for life science startups.
Unlock strategies and best practices for raising capital at the annual Women Founders and Funders breakfast, presented by Fox Rothschild and the Private Investors Forum.
Connect with key players from the private equity, venture capital, and entrepreneurial communities in a vibrant mix of company presentations and networking.
The symposium will highlight advances in the science and development of blood substitutes, with KaloCyte as a Silver Sponsor.
A celebration of Maryland’s entrepreneurial resources, featuring discussions on capital pathways for women entrepreneurs.
A new candidate, ErythroMer, is still in preclinical testing but could be more durable and versatile than the real thing.
The research park’s location and resources make it invaluable for life science startups.